Interleukin-2
This graph shows the total number of publications written about "Interleukin-2" by people in the URMC Research Network by year, and whether "Interleukin-2" was a major or minor topic of these publication.
Below are the most recent publications written about "Interleukin-2" by people in Profiles.
-
Tu Z, Hamalainen-Laanaya HK, Crispe IN, Orloff MS. Synergy between TLR3 and IL-18 promotes IFN-? dependent TRAIL expression in human liver NK cells. Cell Immunol. 2011; 271(2):286-91.
-
Dao H, Barr PM, Honda K. Regression of CD30+ cutaneous anaplastic large-cell lymphoma with denileukin diftitox. J Am Acad Dermatol. 2011 Jun; 64(6):e123-5.
-
Puskas J, Skrombolas D, Sedlacek A, Lord E, Sullivan M, Frelinger J. Development of an attenuated interleukin-2 fusion protein that can be activated by tumour-expressed proteases. Immunology. 2011 Jun; 133(2):206-20.
-
Hilchey SP, Kobie JJ, Cochran MR, Secor-Socha S, Wang JC, Hyrien O, Burack WR, Mosmann TR, Quataert SA, Bernstein SH. Human follicular lymphoma CD39+-infiltrating T cells contribute to adenosine-mediated T cell hyporesponsiveness. J Immunol. 2009 Nov 15; 183(10):6157-66.
-
Li H, Chen X, Jin X, Liu Z, Huang X, Cao Z, Guo C, Dong T, Wu H. Proliferation, but not interleukin 2 production, of Gag-specific CD8+ T cells is associated with low HIV viremia and high CD4 counts in HIV-1-infected Chinese individuals. J Acquir Immune Defic Syndr. 2009 Sep 1; 52(1):1-8.
-
Cycon KA, Clements JL, Holtz R, Fuji H, Murphy SP. The immunogenicity of L1210 lymphoma clones correlates with their ability to function as antigen-presenting cells. Immunology. 2009 Sep; 128(1 Suppl):e641-51.
-
Wilson EB, Livingstone AM. Cutting edge: CD4+ T cell-derived IL-2 is essential for help-dependent primary CD8+ T cell responses. J Immunol. 2008 Dec 1; 181(11):7445-8.
-
Sanchez-Lockhart M, Graf B, Miller J. Signals and sequences that control CD28 localization to the central region of the immunological synapse. J Immunol. 2008 Dec 1; 181(11):7639-48.
-
Lazarski CA, Hughson A, Sojka DK, Fowell DJ. Regulating Treg cells at sites of inflammation. Immunity. 2008 Oct 17; 29(4):511; author reply 512.
-
Thompson JA, Fisher RI, Leblanc M, Forman SJ, Press OW, Unger JM, Nademanee AP, Stiff PJ, Petersdorf SH, Fefer A. Total body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood stem-cell transplantation followed by randomization to therapy with interleukin-2 versus observation for patients with non-Hodgkin lymphoma: results of a phase 3 randomized trial by the Southwest Oncology Group (SWOG 9438). Blood. 2008 Apr 15; 111(8):4048-54.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
|
